↓ Skip to main content

Galantamine for Alzheimer's disease and mild cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, January 2006
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

twitter
3 tweeters
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
284 Dimensions

Readers on

mendeley
219 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Galantamine for Alzheimer's disease and mild cognitive impairment
Published in
Cochrane database of systematic reviews, January 2006
DOI 10.1002/14651858.cd001747.pub3
Pubmed ID
Authors

Clement Loy, Lon Schneider

Abstract

Galantamine is a specific, competitive, and reversible acetylcholinesterase inhibitor.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 219 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 2 <1%
Singapore 1 <1%
Ireland 1 <1%
Brazil 1 <1%
Belgium 1 <1%
Spain 1 <1%
Japan 1 <1%
France 1 <1%
Other 0 0%
Unknown 208 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 16%
Student > Bachelor 30 14%
Student > Ph. D. Student 28 13%
Student > Master 24 11%
Student > Doctoral Student 16 7%
Other 49 22%
Unknown 37 17%
Readers by discipline Count As %
Medicine and Dentistry 65 30%
Psychology 19 9%
Pharmacology, Toxicology and Pharmaceutical Science 15 7%
Chemistry 13 6%
Agricultural and Biological Sciences 13 6%
Other 54 25%
Unknown 40 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2021.
All research outputs
#5,356,454
of 19,069,422 outputs
Outputs from Cochrane database of systematic reviews
#7,646
of 11,929 outputs
Outputs of similar age
#68,787
of 270,021 outputs
Outputs of similar age from Cochrane database of systematic reviews
#132
of 187 outputs
Altmetric has tracked 19,069,422 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 11,929 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.0. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,021 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 187 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.